Pharmaceutical Industry Meeting: Invitation to Participate Virtually

Pharmaceutical Industry Meeting: Invitation to Participate Virtually

Tashkent, Uzbekistan | 16 October 2026

UNICEF Afghanistan Country Office, in collaboration with UNICEF Uzbekistan Country Office, invites pharmaceutical manufacturers, and distributors from Uzbekistan, Kazakhstan, Türkiye, and neighboring countries to participate virtually in the Pharmaceutical Industry Meeting to be held in Tashkent, Uzbekistan, on 16 October 2026.

Virtual Participation

Meeting Link: Join Zoom Meeting
https://unicef.zoom.us/j/99444777615

Password: 172572

Background

This consultation is being organized following the Request for Information (RFI) launched by UNICEF Afghanistan Country Office in June 2026 to better understand the pharmaceutical manufacturing and distribution landscape in the region and to explore opportunities for improving access to quality-assured essential medicines for children and women in Afghanistan.

The consultation will provide an opportunity for direct engagement between UNICEF and the pharmaceutical industries from Uzbekistan, Kazakhstan, Türkiye, and neighboring countries, building on insights gathered through the RFI process and fostering dialogue on market capacity, quality standards, procurement requirements, and potential collaboration opportunities.

Key Topics

• Pharmaceutical market opportunities in Afghanistan
• UNICEF pharmaceutical procurement processes and supplier engagement
• Quality assurance and technical requirements for medicines
• Pharmaceutical procurement localization and regional sourcing opportunities
• Industry perspectives, challenges, and opportunities
• Interactive question-and-answer session

Who Should Attend?

• Pharmaceutical manufacturers
• Pharmaceutical distributors and wholesalers

Important Notes

This Industry meeting is for information-gathering purposes only and does not constitute a solicitation, tender, or commitment to procure. Submission does not guarantee participation in future procurement.

We look forward to your participation in this important regional dialogue aimed at strengthening access to quality-assured medicines and expanding collaboration across the pharmaceutical sector.